4 stories from 2 sources
Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.
A curated list of other prominent stories from this day.
Researchers report that cannabis-derived terpenes reduced pain in mouse models of fibromyalgia and post-surgical pain, with geraniol showing strong effects. The compounds are not linked to THC-like psychoactive effects, positioning them as potential non-intoxicating analgesics.
11:33 AMScienceDailyResearchers found that EXO1, a DNA repair gene, can become harmful when overexpressed, cutting DNA beyond its normal repair targets. That excess cutting creates DNA damage patterns associated with cancer biology.
8:27 AMScienceDailyGLP-1 drugs such as Ozempic have reset expectations for obesity care, delivering larger and more consistent weight loss than prior medications. Clinicians now expect the next phase to combine drugs with minimally invasive procedures, bariatric surgery, and precision approaches to sustain results and tailor treatment.
7:28 AMScienceDailyFamilies of suspected Ebola patients in eastern DR Congo broke into a quarantine and treatment centre and took patients out. The incident disrupted isolation measures designed to stop transmission.
6:09 AMAl JazeeraSummary
Researchers report that cannabis-derived terpenes reduced pain in mouse models of fibromyalgia and post-surgical pain, with geraniol showing strong effects. The compounds are not linked to THC-like psychoactive effects, positioning them as potential non-intoxicating analgesics.
Why it matters
Non-intoxicating, cannabis-derived pain drugs could expand options beyond opioids and THC if they survive the jump from mice to patients.
Summary
Researchers found that EXO1, a DNA repair gene, can become harmful when overexpressed, cutting DNA beyond its normal repair targets. That excess cutting creates DNA damage patterns associated with cancer biology.
Why it matters
It points to a new way to target cancers by exploiting DNA repair overactivity, not just repair loss.
Summary
GLP-1 drugs such as Ozempic have reset expectations for obesity care, delivering larger and more consistent weight loss than prior medications. Clinicians now expect the next phase to combine drugs with minimally invasive procedures, bariatric surgery, and precision approaches to sustain results and tailor treatment.
Why it matters
If treatment moves to planned combinations, coverage and care delivery models will determine who gets durable benefits versus short-term weight loss.
Summary
Families of suspected Ebola patients in eastern DR Congo broke into a quarantine and treatment centre and took patients out. The incident disrupted isolation measures designed to stop transmission.
Why it matters
Once quarantine is breached, Ebola containment shifts from clinical control to community-level crisis, increasing outbreak risk and response costs.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!